BLC
IDXX icon

Brown, Lisle/Cummings’s Idexx Laboratories IDXX Stock Holding History

Brown, Lisle/Cummings’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.3K Sell
29
-2
-6% -$1.12K ﹤0.01% 550
2026
Q1 		$17.4K Buy
31
+29
+1,450% +$18.6K ﹤0.01% 492
2025
Q4 		$1.35K Hold
2
– – ﹤0.01% 671
2025
Q3 		$1.28K Hold
2
– – ﹤0.01% 685
2025
Q2 		$1.07K Hold
2
– – ﹤0.01% 703
2025
Q1 		$840 Buy
+2
New +$868 ﹤0.01% 723

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Brown, Lisle/Cummings's IDXX Position: Q2 2026 in Review

Brown, Lisle/Cummings reduced its Idexx Laboratories (IDXX) stake by 6.5% in Q2 2026, selling an estimated $1.12K and leaving 29 shares worth $15.3K. The position accounts for ﹤0.01% of the portfolio, ranked #550.

Brown, Lisle/Cummings first reported a position in IDXX in Q1 2025 and has held it in 6 quarters since. The position peaked at $17.4K in Q1 2026. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Brown, Lisle/Cummings held 29 shares of Idexx Laboratories worth $15.3K as of Q2 2026.
  • Brown, Lisle/Cummings sold 2 Idexx Laboratories shares in Q2 2026, an estimated $1.12K.
  • Idexx Laboratories made up ﹤0.01% of Brown, Lisle/Cummings's portfolio in Q2 2026, its #550 holding.
  • Brown, Lisle/Cummings first reported a position in Idexx Laboratories in Q1 2025 and has held it in 6 quarters since.
  • Brown, Lisle/Cummings's Idexx Laboratories position peaked at $17.4K in Q1 2026.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q2 2026, filed 2 Sep 2026.